Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #212872 on Innovation Pharmaceuticals Inc (IPIX)
cabel
01/15/18 12:39 PM
#212875 RE: pix #212872
Achieved primary endpoint against placebo (p=0.024) demonstrating a statistically significant and clinically meaningful reduction of 92 percent in the duration of severe oral mucositis (SOM)
Echo20
01/15/18 3:25 PM
#212912 RE: pix #212872
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads